Immunocore Holdings (IMCR) Revenue Growth (1y) (2022 - 2026)
Immunocore Holdings (IMCR) Revenue Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,222.41 Bn | 67,222.13 Bn | - | - |
| 2 | Nanobiotix | 1,909.44 Bn | 1,909.38 Bn | - | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - | - |
| 4 | BeOne Medicines | 471.12 Bn | 466.33 Bn | 1.35 Bn | 35.46% |
| 5 | Vertex Pharmaceuticals | 121.84 Bn | 114.59 Bn | 2.59 Bn | 7.82% |
| 6 | Regeneron Pharmaceuticals | 69.89 Bn | 61.14 Bn | 3.31 Bn | 19.04% |
| 7 | Belite Bio | 62.74 Bn | 62.74 Bn | - | - |
| 8 | Argenx Se | 55.83 Bn | 50.64 Bn | 1.41 Bn | 64.03% |
| 9 | Alnylam Pharmaceuticals | 37.34 Bn | 34.34 Bn | 959.66 Mn | 96.43% |
| 10 | Immunocore Holdings | 1.73 Bn | 888.63 Mn | 106.24 Mn | 13.63% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.63% |
| Dec 31, 2025 | 24.30% |
| Sep 30, 2025 | 29.22% |
| Jun 30, 2025 | 29.93% |
| Mar 31, 2025 | 33.16% |
| Dec 31, 2024 | 19.80% |
| Sep 30, 2024 | 23.74% |
| Jun 30, 2024 | 26.18% |
| Mar 31, 2024 | 28.99% |
| Dec 31, 2023 | 24.46% |
| Sep 30, 2023 | 33.56% |
| Jun 30, 2023 | 48.28% |
| Dec 31, 2022 | 534.30% |
| Sep 30, 2022 | 494.55% |